These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34607401)

  • 1. COVID-19 outbreak, herd immunity formation, and future public health strategies.
    Kim Y; Park YH
    Epidemiol Health; 2021; 43():e2021071. PubMed ID: 34607401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of New Stringency Indices for Nonpharmacological Social Distancing Policies Implemented in Korea During the COVID-19 Pandemic: Random Forest Approach.
    Apio C; Han K; Lee D; Lee B; Park T
    JMIR Public Health Surveill; 2024 Jan; 10():e47099. PubMed ID: 38190233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia.
    Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA
    BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
    She J; Hou D; Chen C; Bi J; Song Y
    Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
    MacIntyre CR; Costantino V; Trent M
    Vaccine; 2022 Apr; 40(17):2506-2513. PubMed ID: 33958223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of application of herd immunity as a control strategy for COVID-19].
    Wu ZY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):986-989. PubMed ID: 32397700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The devil in the details: Herd immunity and pandemic response.
    Schaeffer B; Taylor B; Bushman M; Hanage WP
    Cell Host Microbe; 2021 Jul; 29(7):1048-1051. PubMed ID: 34265244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to the COVID-19 Pandemic: Comparison of Strategies in Six Countries.
    Chen H; Shi L; Zhang Y; Wang X; Jiao J; Yang M; Sun G
    Front Public Health; 2021; 9():708496. PubMed ID: 34660510
    [No Abstract]   [Full Text] [Related]  

  • 9. Policy stringency and mental health during the COVID-19 pandemic: a longitudinal analysis of data from 15 countries.
    Aknin LB; Andretti B; Goldszmidt R; Helliwell JF; Petherick A; De Neve JE; Dunn EW; Fancourt D; Goldberg E; Jones SP; Karadag O; Karam E; Layard R; Saxena S; Thornton E; Whillans A; Zaki J
    Lancet Public Health; 2022 May; 7(5):e417-e426. PubMed ID: 35461592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of Confirmed COVID-19 Cases Among Korean Military Personnel After Mass Vaccination.
    Shin DH; Oh HS; Jang H; Lee S; Choi BS; Kim D
    J Korean Med Sci; 2022 Jan; 37(3):e23. PubMed ID: 35040298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical Estimation of Effects of Implemented Government Policies on COVID-19 Situation in South Korea.
    Heo G; Apio C; Han K; Goo T; Chung HW; Kim T; Kim H; Ko Y; Lee D; Lim J; Park T
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33671746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach.
    Khalife J; VanGennep D
    Epidemiol Health; 2021; 43():e2021012. PubMed ID: 33541010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for Digital Technologies in Containment and Mitigation Strategies: Experience from South Korea COVID-19.
    Heo K; Lee D; Seo Y; Choi H
    Ann Glob Health; 2020 Aug; 86(1):109. PubMed ID: 32944506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to COVID-19 in South Korea and implications for lifting stringent interventions.
    Dighe A; Cattarino L; Cuomo-Dannenburg G; Skarp J; Imai N; Bhatia S; Gaythorpe KAM; Ainslie KEC; Baguelin M; Bhatt S; Boonyasiri A; Brazeau NF; Cooper LV; Coupland H; Cucunuba Z; Dorigatti I; Eales OD; van Elsland SL; FitzJohn RG; Green WD; Haw DJ; Hinsley W; Knock E; Laydon DJ; Mellan T; Mishra S; Nedjati-Gilani G; Nouvellet P; Pons-Salort M; Thompson HA; Unwin HJT; Verity R; Vollmer MAC; Walters CE; Watson OJ; Whittaker C; Whittles LK; Ghani AC; Donnelly CA; Ferguson NM; Riley S
    BMC Med; 2020 Oct; 18(1):321. PubMed ID: 33032601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social restriction versus herd immunity policies in the early phase of the SARS-CoV-2 pandemic: A mathematical modelling study.
    Chancharoenthana W; Leelahavanichkul A; Chinpraditsuk S; Pongpirul K; Kamolratanakul S; Phumratanaprapin W; Wilairatana P; Pitisuttithum P
    Asian Pac J Allergy Immunol; 2023 Sep; 41(3):253-262. PubMed ID: 33386788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Outbreak in Daegu City, Korea and Response to COVID-19: How Have We Dealt and What Are the Lessons?
    Kim SW
    J Korean Med Sci; 2022 Dec; 37(50):e356. PubMed ID: 36573388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
    Chun JY; Jeong H; Kim Y
    J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.
    Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.